Fierce Healthcare September 11, 2019
The Apple Watch received FDA clearance last year for its electrocardiogram feature, officially classifying it as a medical device capable of alerting its user to abnormal heart rhythms.
“With the Apple Heart Study, we found that we could positively impact medical research in ways that help patients today and that make contributions that will benefit future generations,” Jeff Williams, Apple’s chief operating officer, said in a statement. “Today’s announcement carries our commitment to health even further by engaging with participants on a larger scale than ever before.”
A University of California San Francisco study assessing the Apple Watch’s ability to predict irregular heartbeats poured some cold water on the capabilities of the technology. The study found that the Apple Watch...
Today's Sponsors
Today's Sponsor